Anthropic IPO Date: What We Know Before Shares Hit the Nasdaq
Decode the Anthropic IPO date, the $70 to $78 price range and the legal risks behind the listing, with what is confirmed, what is reported and what investors still cannot know.

Key Takeaways
- No official Anthropic IPO date yet: reports point to November 19, but until Nasdaq says so, it is a rumor with good posture.
- The price range is $70 to $78 a share, and the ticker is ANT.
- A $26 billion private placement sits outside the $64.35 billion headline raise.
- Revenue of $33.2 billion is real, and so is a net loss of about $104 billion.
- Legal liability that insurers are reluctant to touch is the new line item on the investor checklist.

Everyone wants to know the Anthropic IPO date. The honest answer is a moving target.
Reports point to a first trade on November 19, and the price range sits at $70 to $78 a share. Nothing, though, is signed and sealed. Behind the buzz sit a $26 billion private placement and a stack of risks investors have never met before.
This guide separates what is confirmed from what is chatter. Let's get started.
Tracking the Anthropic IPO Date
A date on the calendar and a date on the record are different animals. Think of the Anthropic IPO date as a train time chalked on a station board: everyone is reading it, and the railway has yet to sign off. Right now the paperwork is public; the day itself is not.
Anthropic filed its public S-1 on October 26, and reports point to a first trade on November 19, ahead of Thanksgiving. Other reports name November 20. The roadshow is already under way, and pricing follows it.
Yet nothing is official. As of November 12, Anthropic had announced no date, and every timeline stays subject to change. Three signals settle it: an effective registration statement, a pricing announcement, and a Nasdaq notice that ANT is about to trade. Until then, every date is a report, not a fact.
Pricing the Anthropic IPO
Picture a shop window with a price tag written in pencil. Anthropic plans to sell 825 million shares at $70 to $78 each, and the final price is set the evening before trading starts. Nasdaq will list it under the ticker ANT.
At the top of the range, the sale raises about $64.35 billion, which implies a fully diluted value of about $1.4 trillion. The filing's own math, measured on shares outstanding after the offering, lands lower. Same company, two yardsticks, and a gap worth a double take.
Don't treat the range as a fence. The opening price can land above or below it, and a brokerage request guarantees nothing when demand beats supply. Anyone who misses the allocation can still buy once ANT starts trading. Patience is a position too. Access also varies by country, so international investors should check with their brokerage.
Following the Private Placement
Big money votes first. Before a single retail order lands, a private placement of $26 billion is spoken for, all at the IPO price, per Anthropic's updated SEC filing. Think of it as the VIP rope line at the club.
Google and Nvidia each take $10.0 billion, the lion's share. AMD, Broadcom, Micron, Microsoft and TSMC split the rest. Chipmakers and cloud giants are buying the story at the same sticker price as everyone else, a who's who of tech.
That cash sits outside the headline raise, since the $64.35 billion figure excludes it. Up to 20% of the offering is open to retail investors. Eligible customers at Fidelity, Robinhood, Charles Schwab, SoFi and E*TRADE can request shares, and Fidelity set an expected deadline for requests ahead of pricing.
Judging Revenue Against Losses
Imagine a rocket whose thrust keeps climbing while the fuel gauge swings wildly. Anthropic, maker of the Claude AI assistant, reports revenue of $33.2 billion in the first nine months of 2026, growth of about 1,206%. Thousands of enterprise customers generate recurring business for the company.
Third-quarter revenue hit $16.96 billion, up about 47% from the second quarter, yet the company slipped to a GAAP operating loss after an operating profit in that quarter. Growth is real; so is the bill. Competition from OpenAI, Google and other AI developers is named as a risk.
The loss of about $104 billion over nine months looks terrifying. Anthropic ties it to expansion costs and accounting adjustments, and in the first half most of the hit was a non-cash change in the fair value of convertible notes, not cash spent.
Facing Uninsurable AI Risks
Who pays when an AI agent goes off script? Insurers are reluctant to touch catastrophic legal liability, and Anthropic's prospectus warns of "significant and unpredictable" legal claims over its agents' actions. This is the first frontier AI lab to list its shares, so investors are pricing risks they have never met.
PocketOS, a Utah small business, lost months of records in nine seconds after an Anthropic coding agent, accessed through Cursor, tried to fix a problem on its own. The data came back with a partner's help. The question of fault stays open: user, vendor or model developer.
Washington is circling. At least 56 federal bills aim to rein in AI, according to the Brennan Center for Justice, and Treasury Secretary Scott Bessent urged Congress not to grant the liability waiver Amodei proposed. Liability is now a line item on every investor's risk list.
Long Story Short
Strip away the noise and the picture is clear. Anthropic has a Nasdaq listing, the ANT ticker and a range of $70 to $78, but the final price and the listing day wait until the evening before trading. Revenue of $33.2 billion in nine months sits beside a net loss of about $104 billion, and uninsurable-style legal risk sits beside both. So treat the date as a report until the pricing announcement lands. Check EDGAR and Anthropic's newsroom for confirmation, and remember that a retail request is an invitation, not a guarantee. Eight of the ten largest IPOs from 1999 to 2023 fell in their first three months, so a hot debut is no promise. The smarter move is patience: read the S-1, decide your size, and let the opening bell do its shouting first. This debut is the first public test of a dedicated frontier AI lab, and it tests investor confidence in AI itself. Whatever the first trade brings, the story is only beginning.